PA
NVNO

Perceptive Advisors’s enVVeno Medical NVNO Stock Holding History

Perceptive Advisors’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-50,258
Closed -$564K – 120
2025
Q4 		$564K Hold
50,258
– – 0.01% 112
2025
Q3 		$1.59M Buy
50,258
+13,545
+37% +$1.38M 0.05% 83
2025
Q2 		$5.13M Buy
+36,713
New +$4.34M 0.19% 67
2024
Q4 		– Sell
-19,838
Closed -$2.33M – 114
2024
Q3 		$2.33M Buy
19,838
+2,029
+11% +$373K 0.05% 92
2024
Q2 		$3.27M Hold
17,809
– – 0.08% 88
2024
Q1 		$3.39M Hold
17,809
– – 0.06% 98
2023
Q4 		$3.2M Sell
17,809
-4,523
-20% -$720K 0.07% 82
2023
Q3 		$4.21M Hold
22,332
– – 0.14% 73
2023
Q2 		$2.41M Hold
22,332
– – 0.07% 81
2023
Q1 		$3.66M Hold
22,332
– – 0.11% 82
2022
Q4 		$3.99M Hold
22,332
– – 0.11% 74
2022
Q3 		$4.91M Hold
22,332
– – 0.14% 82
2022
Q2 		$2.95M Hold
22,332
– – 0.09% 91
2022
Q1 		$4.98M Hold
22,332
– – 0.1% 105
2021
Q4 		$5.15M Buy
+22,332
New +$6.29M 0.08% 118

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Perceptive Advisors's NVNO Position: Q1 2026 in Review

Perceptive Advisors sold out of enVVeno Medical (NVNO) in Q1 2026, closing a stake of 50,258 shares — an estimated $564K sold.

Perceptive Advisors first reported a position in NVNO in Q4 2021 and held it in 15 quarters. The position peaked at $5.15M in Q4 2021. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

  • Perceptive Advisors reported no remaining enVVeno Medical position as of Q1 2026 after selling out during the quarter.
  • Perceptive Advisors sold 50,258 enVVeno Medical shares in Q1 2026, an estimated $564K.
  • Perceptive Advisors first reported a position in enVVeno Medical in Q4 2021 and held it in 15 quarters.
  • Perceptive Advisors's enVVeno Medical position peaked at $5.15M in Q4 2021.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on Perceptive Advisors's 13F filing for Q1 2026, filed 15 May 2026.